A 52 week randomised double-blind placebo-controlled study to investigae the efficacy and sagety of GSK 1605786A in the maintenance of remission in subjects with Crohns Disease
- Chung, Alvin, (Primary Chief Investigator (PCI))
Project: Research
Project: Research